Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Adenocarcinoma 1

Interventions

Specimen Handling 176 Magnetic Resonance Spectroscopy 138 Biopsy 102 pembrolizumab 81 Carboplatin 79 Cisplatin 71 Nivolumab 65 Cyclophosphamide 64 Paclitaxel 54 Radiotherapy 48 Gemcitabine 43 durvalumab 39 Doxorubicin 35 Bevacizumab 34 Fluorouracil 33 venetoclax 32 Dexamethasone 31 Rituximab 30 atezolizumab 29 Radiation 29 Capecitabine 28 Lenalidomide 27 Etoposide 27 Prednisone 26 Oxaliplatin 26 Injections 26 Pemetrexed 25 Docetaxel 25 olaparib 23 fludarabine 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × paricalcitol × 30 days × Clear all

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed

34 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡